Kynmobi (Apomorphine Hydrochloride Sachets) 10mg

Kynmobi (Apomorphine Hydrochloride) 10mg sachets offer fast-acting relief for off episodes in Parkinson’s disease. This oral film sachet formulation provides convenience for patients seeking rapid symptom management. Store at 15-25°C to maintain potency.

Strength

10mg

Pack Size

30s

Storage

15-25°

Manufacturer / TM Owner

Sunovion Pharmaceuticals USA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kynmobi is used to treat sudden off episodes in Parkinson’s disease when mobility becomes impaired. It works by stimulating dopamine receptors to restore movement temporarily. Patients experiencing unpredictable periods of stiffness or slowness may benefit from this medication.

Side Effects

Users typically notice improved mobility within 15-30 minutes after taking Kynmobi. The effects can last up to 90 minutes, helping patients regain control during off periods. Some may experience mild nausea or dizziness as the body adjusts to the medication.

Precautions & Warnings

Keep Kynmobi sachets in their original packaging until use to protect from moisture. Do not use if the sachet is damaged or the film appears discolored. Always follow your healthcare provider’s instructions for proper storage and handling.

Avoid Interactions

Kynmobi may interact with medications that affect blood pressure or heart rate. Alcohol and sedatives can enhance drowsiness when combined with this drug. Always inform your doctor about all medications you’re taking before starting Kynmobi.

References

Frequently Asked Questions

Kynmobi is used to treat sudden off episodes in Parkinson’s disease when mobility becomes impaired.

Users typically notice improved mobility within 15-30 minutes after taking Kynmobi.

Kynmobi may interact with certain medications; consult your healthcare provider before combining treatments.

Store Kynmobi at 15-25°C in the original packaging to maintain potency and protect from moisture.

Some users may experience mild nausea or dizziness as the body adjusts to the medication.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.